These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 6386981

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
    Redlich PN, Grossberg SE.
    J Immunol; 1989 Sep 15; 143(6):1887-93. PubMed ID: 2476486
    [Abstract] [Full Text] [Related]

  • 3. Characterization of E. coli-derived recombinant human interferon-beta as compared with fibroblast human interferon-beta.
    Utsumi J, Yamazaki S, Hosoi K, Kimura S, Hanada K, Shimazu T, Shimizu H.
    J Biochem; 1987 May 15; 101(5):1199-208. PubMed ID: 3308862
    [Abstract] [Full Text] [Related]

  • 4. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
    Meager A, Das RG.
    J Immunol Methods; 2005 Nov 30; 306(1-2):1-15. PubMed ID: 16226271
    [Abstract] [Full Text] [Related]

  • 5. Antiviral action of tumor necrosis factor in human fibroblasts is not mediated by B cell stimulatory factor 2/IFN-beta 2, and is inhibited by specific antibodies to IFN-beta.
    Reis LF, Le JM, Hirano T, Kishimoto T, Vilcek J.
    J Immunol; 1988 Mar 01; 140(5):1566-70. PubMed ID: 3279118
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal antibodies for affinity purification of IL-6/IFN- beta 2 and for neutralization of HGF activity.
    Novick D, Eshhar Z, Revel M, Mory Y.
    Hybridoma; 1989 Oct 01; 8(5):561-7. PubMed ID: 2680901
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibodies that distinguish between subspecies of human interferon-alpha and that detect interferon oligomers.
    Shearer M, Taylor-Papadimitriou J, Griffin D, Balkwill F.
    J Immunol; 1984 Dec 01; 133(6):3096-101. PubMed ID: 6491281
    [Abstract] [Full Text] [Related]

  • 8. Incidence of antibodies to interferon-beta in patients treated with recombinant human interferon-beta 1a from mammalian cells.
    Abdul-Ahad AK, Galazka AR, Revel M, Biffoni M, Borden EC.
    Cytokines Cell Mol Ther; 1997 Mar 01; 3(1):27-32. PubMed ID: 9287241
    [Abstract] [Full Text] [Related]

  • 9. [Cloning and expression of murine Toll-like receptor-2 N terminal and preparation of its antibody].
    Yang CL, Zhao WZ, Liu YJ, Zhu P, Fu N.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov 01; 26(11):1609-11, 1615. PubMed ID: 17121712
    [Abstract] [Full Text] [Related]

  • 10. Two monoclonal antibodies distinguish between human recombinant interferon-alpha 5s produced by Escherichia coli and by mouse cells.
    Tsukui K, Fukunaga R, Nagata S, Ito K.
    Microbiol Immunol; 1986 Nov 01; 30(12):1271-9. PubMed ID: 2437432
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The nature of neutralization reaction between effector protein and monoclonal antibody: a quantitative study of neutralization characteristics of anti-interferon antibodies.
    Kawade Y, Watanabe Y.
    Immunology; 1985 Nov 01; 56(3):489-95. PubMed ID: 4077097
    [Abstract] [Full Text] [Related]

  • 13. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.
    Davies J, Jiang L, Pan LZ, LaBarre MJ, Anderson D, Reff M.
    Biotechnol Bioeng; 2001 Aug 20; 74(4):288-94. PubMed ID: 11410853
    [Abstract] [Full Text] [Related]

  • 14. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation.
    Walter DH, Hink U, Asahara T, Van Belle E, Horowitz J, Tsurumi Y, Vandlen R, Heinsohn H, Keyt B, Ferrara N, Symes JF, Isner JM.
    Lab Invest; 1996 Feb 20; 74(2):546-56. PubMed ID: 8780172
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of the neutralizing properties of monoclonal and polyclonal antibodies to human interferon alpha.
    Exley T, Parti S, Barwick S, Meager A.
    J Gen Virol; 1984 Dec 20; 65 ( Pt 12)():2277-80. PubMed ID: 6512507
    [Abstract] [Full Text] [Related]

  • 17. Purification of the major species of human leucocyte interferon with the help of a monoclonal antibody.
    Laurent AG, Gruest J, Svab J, Montagnier L, Meurs E.
    Dev Biol Stand; 1984 Dec 20; 57():305-10. PubMed ID: 6084617
    [Abstract] [Full Text] [Related]

  • 18. B-1a cell origin of the murine B lymphoma line BCL1 characterized by surface markers and bacterial reactivity of its surface IgM.
    Koganei S, Ito M, Yamamoto K, Matsumoto N.
    Immunol Lett; 2005 May 15; 98(2):232-44. PubMed ID: 15860223
    [Abstract] [Full Text] [Related]

  • 19. Purification of human gamma interferon receptors by sequential affinity chromatography on immobilized monoclonal antireceptor antibodies and human gamma interferon.
    Aguet M, Merlin G.
    J Exp Med; 1987 Apr 01; 165(4):988-99. PubMed ID: 2435837
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.